Table 2.
Comparison of primary outcome measures at 6 months postintervention.
| Primary outcome variables | Control (n=123), n (%) | Intervention (n=109), n (%) | Difference, % | 95% CI | P value |
| Ever tested for HIV | 95 (77.2) | 83 (76.2) | –1.1 | –11.9 to 9.9 | .85 |
| Ever tested for syphilis | 64 (52.0) | 69 (63.3) | 11.3 | –1.4 to 24.0 | .08 |
| Ever tested for chlamydia and gonorrhea | 51 (41.5) | 56 (51.4) | 9.9 | –2.9 to 22.7 | .13 |
| Tested for HIV in last 6 months | 41 (33.3) | 42 (38.5) | 5.2 | –7.1 to 17.5 | .41 |
| Tested for syphilis in last 6 months | 31 (25.2) | 30 (27.5) | 2.3 | –9.0 to 13.6 | .69 |
| Tested for chlamydia and gonorrhea in last 6 months | 22 (17.9) | 25 (22.9) | 5.1 | –5.3 to 15.3 | .34 |
| Tested regularly (at least yearly) for HIV | 55 (44.7) | 66 (60.6) | 15.8 | 3.2 to 28.6 | .02 |
| Tested regularly (at least yearly) for syphilis | 36 (29.3) | 43 (39.5) | 10.2 | –2.0 to 22.4 | .10 |
| Tested regularly (at least yearly) for chlamydia and gonorrhea | 25 (20.3) | 39 (35.8) | 15.5 | 4.2 to 26.9 | .009 |
| Intention to test for HIV in the next 3 months | 36 (29.3) | 50 (45.9) | 16.6 | 4.3 to 28.9 | .009 |
| Intention to test for syphilis in the next 3 months | 28 (22.8) | 41 (37.6) | 14.8 | 3.2 to 26.4 | .01 |
| Intention to test for chlamydia and gonorrhea in the next 3 months | 24 (19.5) | 38 (34.9) | 15.4 | 4.2 to 26.6 | .008 |